AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Argenica Therapeutics Ltd

0.140

0.000

Volume:4K

Turnover:500

Market Cap:17.98M

PE:-12.73

High:0.140

Open:0.140

Low:0.140

Close:0.140

52wk High:0.345

52wk Low:0.087

Shares:128.46M

Float Shares:91.53M

Volume Ratio:0.04

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.011

EPS(LYR):-0.011

ROE:-20.78%

ROA:-11.23%

PB:3.05

PE(LYR):-12.73

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Argenica Therapeutics - no Dividend Has Been Declared

THOMSON REUTERS

Argenica Therapeutics Ltd - FY Revenues from Ordinary Activities A$5.7 Mln

THOMSON REUTERS

Argenica's Drug Candidate for Severe Strokes Represents 'Highly Commercially Attractive Opportunity,' Euroz Hartleys Says

MT Newswires Live

Argenica Therapeutics Ltd-Arg007 (Xaranetide) Completes All Three FDA Requested Assays

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/AGN.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AGN.AU\",,,,,undefined,":{"symbol":"AGN.AU","market":"AU","secType":"STK","nameCN":"Argenica Therapeutics Ltd","latestPrice":0.14,"timestamp":1790835120000,"preClose":0.14,"halted":0,"volume":3573,"delay":0,"changeRate":0,"nameEN":"Argenica Therapeutics Ltd","floatShares":91529130,"shares":128456712,"eps":-0.010999,"marketStatus":"Closed","change":0,"latestTime":"10-01 16:12:00 AEST","open":0.14,"high":0.14,"low":0.14,"amount":500,"amplitude":0,"askPrice":0.14,"askSize":117616,"bidPrice":0.13,"bidSize":80492,"shortable":3,"etf":0,"ttmEps":-0.010999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.14,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":0.036843,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AGN.AU","preClose":0.14,"auctionPrice":0.14,"auctionVolume":3573,"auctionTime":1790834405703,"referencePrice":0.14,"referenceTime":1790850603090,"auction":3,"marketStatus":"盘后竞价","timestamp":1790834405703}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AGN.AU\",,,,,undefined,":{"symbol":"AGN.AU","floatShares":91529130,"roa":"-11.23%","roe":"-20.78%","lyrEps":-0.011,"volumeRatio":0.036843,"shares":128456712,"dividePrice":0,"high":0.14,"amplitude":0,"preClose":0.14,"low":0.14,"week52Low":0.087,"pbRate":"3.05","psRate":"3.28","week52High":0.345,"institutionHeld":0,"latestPrice":0.14,"committee":-0.187393,"eps":-0.010999,"divideRate":0,"volume":3573,"delay":0,"ttmEps":-0.010999,"open":0.14,"prevYearClose":0.295,"prevWeekClose":0.15,"prevMonthClose":0.14,"prevQuarterClose":0.14,"fiveDayClose":0.125,"twentyDayClose":0.18,"sixtyDayClose":0.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGN.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662760714","title":"Argenica Therapeutics - no Dividend Has Been Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760714?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:31","pubTimestamp":1787725875,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0ZH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719760","title":"Argenica Therapeutics Ltd - FY Revenues from Ordinary Activities A$5.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719760?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:31","pubTimestamp":1787725875,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0ZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","AGN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642255266","title":"Argenica's Drug Candidate for Severe Strokes Represents 'Highly Commercially Attractive Opportunity,' Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2642255266","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642255266?lang=en_us&edition=fundamental","pubTime":"2026-06-12 10:00","pubTimestamp":1781229653,"startTime":"0","endTime":"0","summary":"Argenica Therapeutics'  ARG-007 drug candidate is supported by a compelling body of evidence in patients with severe strokes, which represents a \"highly commercially attractive opportunity,\" Euroz Hartleys said in a Friday note.It completed a cardiac safety assay for its ARG-007 drug candidate, the third and final safety study requested by the US Food and Drug Administration, addressing the last outstanding requirement of the clinical hold placed on its Investigational New Drug application to begin trials in the US. This is a key milestone, clearing the path to its proposed Phase 2b trial in ischaemic stroke.In parallel, the firm is advancing ARG-007 toward a Phase 1b trial in traumatic brain injury and is in the final stages of talks with hospital and academic partners. This gives the company a second shot in another large market, with non-dilutive funding adding to the appeal.The investment firm retained its speculative buy rating on Argenica as well as its AU$1.30 per share price ta","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642711054","title":"Argenica Therapeutics Ltd-Arg007 (Xaranetide) Completes All Three FDA Requested Assays","url":"https://stock-news.laohu8.com/highlight/detail?id=2642711054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642711054?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:33","pubTimestamp":1781130789,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUE2H12KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","AGN.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGN.AU\",params:#limit:6,delay:true,,,undefined,":[]}}